IP Library Granted Patent US 7,371,558
Granted Patent B2
US 7,371,558 · App. 10/680,286 · Granted May 13, 2008

Process for the biological production of 1,3-propanediol with high yield

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,558
App. No.
10/680,286
Granted
May 13, 2008
Kind
B2
Abstract

The present invention provides a microorganism useful for biologically producing 1,3-propanediol from a fermentable carbon source at higher yield than was previously known. The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence to produce 1,3-propanediol. The invention provides a microorganism with disruptions in specified genes and alterations in the expression levels of specified genes that is useful in a higher yielding process to produce 1,3-propanediol.

Claims (40)

1. An E. coli strain comprising:

a) a disrupted endogenous phosphoenolpyruvate-glucose phosphotransferase system comprising one or more of:

i) a genetically disrupted endogenous ptsH gene preventing expression of active phosphocarrier protein;

ii) a genetically disrupted endogenous ptsl gene preventing expression of active phosphoenolpyruvate-protein phosphotransferase; and

iii) a genetically disrupted endogenous crr gene preventing expression of active glucose-specific IIA component;

b) a genetically up regulated endogenous galP gene encoding active galactose-proton symporter, said up regulation resulting in an increased galactose-proton symporter activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

c) a genetically up regulated endogenous glk gene encoding active glucokinase, said up regulation resulting in an increased glucokinase activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter, and

d) a genetically down regulated endogenous gapA gene encoding active glyceraldehyde 3-phosphate dehydrogenase, said down regulation resulting in a reduced glyceraldehyde 3-phosphate dehydrogenase activity;

whereby said E. coli strain is capable of bioconverting a suitable carbon source to 1,3-propanediol.

2. The E. coli strain of claim 1 , comprising a genetically disrupted endogenous arcA gene preventing expression of active aerobic respiration control protein.

3. An E. coli strain comprising

a) a disrupted endogenous phosphoenolpyruvate-glucose phosphotransferase system comprising one or more of:

i) a genetically disrupted endogenous ptsH gene preventing expression of active phosphocarrier protein;

ii) a genetically disrupted endogenous ptsl gene preventing expression of active phosphoenolpyruvate-protein phosphotransferase; and

iii) a genetically disrupted endogenous crr gene preventing expression of active glucose-specific IIA component;

b) a genetically up regulated endogenous galP gene encoding active galactose-proton symporter, said up regulation resulting in an increased galactose-proton symporter activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

c) a genetically up regulated endogenous glk gene encoding active glucokinase, said up regulation resulting in an increased glucokinase activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

d) a genetically down regulated endogenous gapA gene encoding active glyceraldehyde 3-phosphate dehydrogenase, said down regulation resulting in a reduced glyceraldehyde 3-phosphate dehydrogenase activity;

e) a genetically disrupted endogenous arcA gene preventing expression of active aerobic respiration control protein;

f) a genetically up regulated endogenous ppc gene encoding active phosphoenolpyruvate carboxylase, said up regulation resulting in an increased phosphoenolpyruvate carboxylase activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

g) a genetically up regulated endogenous btuR gene encoding active cob(I)alamin adenosyltransferase, said up regulation resulting in an increased cob(I)alamin adenosyltransferase activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

h) a genetically up regulated yqhD gene encoding active alcohol dehydrogenase, said up regulation resulting in an increased alcohol dehydrogenase activity; wherein the up regulation is produced by a) by introducing additional copies of said gene into host cell followed by integration or b) by replacing native regulatory sequence with strong non-native promoter or altered native promoter

i) a genetically disrupted endogenous mgsA gene preventing the expression of active methylglyoxal synthase;

j) a genetically disrupted endogenous ackA gene preventing the expression of active acetate kinase;

k) a genetically disrupted endogenous pta gene preventing the expression of active phosphotransacetylase;

l) a genetically disrupted endogenous aldA gene preventing the expression of active aldehyde dehydrogenase A;

m) a genetically disrupted endogenous aldB gene preventing the expression of active aldehyde dehydrogenase B;

n) a genetically disrupted endogenous edd gene preventing expression of active phosphogluconate dehydratase;

o) a genetically disrupted endogenous glpK gene preventing expression of active glycerol kinase;

p) a genetically disrupted endogenous gldA gene preventing expression of active NADH-dependent glycerol dehydrogenase; and

q) one plasmid selected from the group consisting of

1) a plasmid comprising

i) a first operon comprising genes encoding glycerol-3-phosphate dehydrogenase and glycerol-3-phosphatase,

ii) a second operon comprising a promoter consisting of the nucleotide sequence set forth in bases 4046-4232 of SEQ ID NO:65, said promoter controlling genes encoding dehydratase and a gene encoding a first subunit of dehydratase reactivation factor,

iii) a third operon comprising a second subunit of dehydratase reactivation factor, and

iv) having the sequence of SEQ ID NO:68;

2) the plasmid of SEQ ID NO:68, optionally containing orfW,

3) the plasmid of 1) or 2); wherein the first operon of i) is present in reverse orientation; and

4) the plasmid of 1), 2) or 3), where a promoter consisting of the nucleotide sequence set forth in bases 4046-4232 of SEQ ID NO:66 replaces the promoter in the second operon of ii),

whereby said E. coli strain is capable of bioconverting a fermentable carbon source to 1,3-propanediol.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2025
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: COVAPDO LLC
Reel/Frame 071435/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENTITY FOR ASSIGNEE PREVIOUSLY RECORDED AT REEL: 49879 FRAME: 212. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 6, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 050301/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 049879/0212 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2004
From: CERVIN, MARGUERITE A.; SOUCAILLE, PHILIPPE; VALLE, FERNANDO
To: E. I. DU PONT DE NEMOURS AND COMPANY; GENENCOR INTERNATIONAL, INC.
Reel/Frame 014525/0651 →